NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, 2025, NMD4C proudly hosted its first Clinical Summer School in Ottawa, ON, welcoming 19 neuromuscular clinical fellows from institutions across the country. Co-chaired by Dr. Gordon Jewitt and Dr. Marianne Nury, the event marked a significant milestone in national efforts to foster excellence in neuromuscular care and education.
The immersive two-day program featured interactive, hands-on workshops led by Canadian experts, including Drs. Alberto Aleman, Grayson Beecher, Ari Breiner, Leslie Hamilton, Hanns Lochmüller, Hugh McMillan, Gerd Melkus, Kiran Polavarapu, Zaeem Siddiqi, and Jodi Warman Chardon. These sessions were designed to complement NMD4C’s Royal College–accredited National Neuromuscular Lecture Series, offering fellows a unique opportunity to refine diagnostic and analytical skills in a collaborative setting.
In addition to clinical training, the Summer School emphasized mentorship and peer connection. A dedicated networking session on Day 1 allowed fellows to build relationships and share experiences, reinforcing the network’s commitment to community-building among early-career researchers.
A highlight of the event was the peer election of Dr. Joaquín Machado and Dr. Bridget Mulvany-Robbins as Co-Chief Neuromuscular Fellows. We also extend our thanks to Dr. Zahra Aleisa for her outstanding service and leadership as our 2024/2025 Chief Neuromuscular Fellow. Her commitment has been instrumental in shaping a supportive and enriching environment for fellows across the network.
To ensure accessibility, NMD4C waived registration fees and provided travel and accommodation support, enabling participation from across Canada. We would like to extend our thanks to our sponsors FUJIFILM Sonosite and CANON Medical, as well as all speakers, fellows, and partners whose contributions made the event a resounding success.
By investing in the next generation of neuromuscular specialists, NMD4C continues to advance its mission of collaborative research, clinical excellence, and national capacity-building in neuromuscular medicine.
Relive the highlights from this event
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.